| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SDZ.SW - | HOLD | 0 @ CHF 63.0955 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 63.0955. The average price that SDZ.SW shares were previous bought at was CHF 46.9107. The current market price is 34.5% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 1,989 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 120.55 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 120.55. The average price that MRK.DE shares were previous bought at was EUR 117.731. The current market price is 2.4% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 118.506 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 118.506. The average price that NOVN.SW shares were previous bought at was CHF 104.297. The current market price is 13.6% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 16,952 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 44.3863 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 44.3863. The average price that NOVO-B.CO shares were previous bought at was DKK 54.3016. The current market price is -18.3% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 1,768 compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 63.55 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 63.55. The average price that ORNBV.HE shares were previous bought at was EUR 59.669. The current market price is 6.5% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 22.74 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 22.74. The average price that PHIA.AS shares were previous bought at was EUR 22.3589. The current market price is 1.7% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 48.68 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 48.68. The average price that REC.MI shares were previous bought at was EUR 52.7383. The current market price is -7.7% lower than average price they were purchased at. EUR 0 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 362.944 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 362.944. The average price that RO.SW shares were previous bought at was CHF 304.239. The current market price is 19.3% higher than average price they were purchased at. The value of the holding in RO.SW has increased by CHF 875 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 354.764 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 354.764. The average price that ROG.SW shares were previous bought at was CHF 288.914. The current market price is 22.8% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 18,755 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 81.61 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 81.61. The average price that SAN.PA shares were previous bought at was EUR 87.044. The current market price is -6.2% lower than average price they were purchased at. EUR 0 compared to the previous valuation of Sanofi SA however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 573.693 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 573.693. The average price that LONN.SW shares were previous bought at was CHF 603.713. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 3,030 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 44.5 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 44.5. The average price that SHL.DE shares were previous bought at was EUR 47.1994. The current market price is -5.7% lower than average price they were purchased at. EUR 0 compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 13.9978 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 13.9978. The average price that SN.L shares were previous bought at was GBP 13.6992. The current market price is 2.2% higher than average price they were purchased at. The value of the holding in SN.L has increased by GBP 1,219 compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 30.5439 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 30.5439. The average price that SOBI.ST shares were previous bought at was SEK 26.7864. The current market price is 14.0% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 5,463 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 221.512 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 221.512. The average price that SOON.SW shares were previous bought at was CHF 260.436. The current market price is -14.9% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 845 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 245.5 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 245.5. The average price that SRT3.DE shares were previous bought at was EUR 217.069. The current market price is 13.1% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 99.9496 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 99.9496. The average price that STMN.SW shares were previous bought at was CHF 109.888. The current market price is -9.0% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 839 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 209 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 209. The average price that TUB.BR shares were previous bought at was EUR 210.25. The current market price is -0.6% lower than average price they were purchased at. EUR 0 compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 235.5 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 235.5. The average price that UCB.BR shares were previous bought at was EUR 189.972. The current market price is 24.0% higher than average price they were purchased at. EUR 0 compared to the previous valuation of UCB SA however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 40.71 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 40.71. The average price that FME.DE shares were previous bought at was EUR 45.9708. The current market price is -11.4% lower than average price they were purchased at. EUR 0 compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 718.6 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 718.6. The average price that ARGX.BR shares were previous bought at was EUR 585.67. The current market price is 22.7% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Argenx SE however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 156.826 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 156.826. The average price that AZN.L shares were previous bought at was GBP 132.331. The current market price is 18.5% higher than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 26,276 compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 35.94 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 35.94. The average price that BAYN.DE shares were previous bought at was EUR 25.5091. The current market price is 40.9% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Bayer AG however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 110 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 110. The average price that BIM.PA shares were previous bought at was EUR 114.199. The current market price is -3.7% lower than average price they were purchased at. EUR 0 compared to the previous valuation of BioMerieux however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 72.6674 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 72.6674. The average price that COLO-B.CO shares were previous bought at was DKK 83.2028. The current market price is -12.7% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 114 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 28.6493 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 28.6493. The average price that DEMANT.CO shares were previous bought at was DKK 32.2794. The current market price is -11.2% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 34 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 205.9 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 205.9. The average price that DIM.PA shares were previous bought at was EUR 192.964. The current market price is 6.7% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 270.1 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 270.1. The average price that EL.PA shares were previous bought at was EUR 263.173. The current market price is 2.6% higher than average price they were purchased at. EUR 0 compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 62.14 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 62.14. The average price that ERF.PA shares were previous bought at was EUR 57.6515. The current market price is 7.8% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 68.2404 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 68.2404. The average price that ALC.SW shares were previous bought at was CHF 73.8693. The current market price is -7.6% lower than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 2,571 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 48.76 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 48.76. The average price that FRE.DE shares were previous bought at was EUR 42.6885. The current market price is 14.2% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 176.629 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 176.629. The average price that GALD.SW shares were previous bought at was CHF 132.226. The current market price is 33.6% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 2,059 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 284.217 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 284.217. The average price that GMAB.CO shares were previous bought at was DKK 209.088. The current market price is 35.9% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 214 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.99 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.99. The average price that GRF.MC shares were previous bought at was EUR 10.6752. The current market price is 2.9% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Grifols SA however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 20.7071 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 20.7071. The average price that GSK.L shares were previous bought at was GBP 17.4295. The current market price is 18.8% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 9,095 compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 17.5818 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 17.5818. The average price that HIK.L shares were previous bought at was GBP 22.3835. The current market price is -21.5% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 319 compared to the previous valuation of however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.26987 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.26987. The average price that HLN.L shares were previous bought at was GBP 4.39824. The current market price is -2.9% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 4,109 compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 120 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 120. The average price that IPN.PA shares were previous bought at was EUR 110.554. The current market price is 8.5% higher than average price they were purchased at. EUR 0 compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-12-26 this would crystalise an overall loss. |